MARKET

JAZZ

JAZZ

Jazz Pharmaceuticals Plc
NASDAQ
169.73
+0.20
+0.12%
After Hours: 169.73 0 0.00% 19:30 12/16 EST
OPEN
168.61
PREV CLOSE
169.53
HIGH
170.24
LOW
167.53
VOLUME
981.59K
TURNOVER
--
52 WEEK HIGH
182.99
52 WEEK LOW
95.49
MARKET CAP
10.31B
P/E (TTM)
-27.9635
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at JAZZ last week (1208-1212)?
Weekly Report · 1d ago
Jazz Pharmaceuticals (JAZZ): Valuation Check After Positive Ziihera and Epidiolex Clinical Updates Boost Investor Interest
Simply Wall St · 2d ago
Jazz Pharmaceuticals Completes Observational Study on Vyxeos Liposomal in AML Treatment
TipRanks · 2d ago
How Fresh Epidiolex and Ziihera Data Accepted at Key Meetings At Jazz Pharmaceuticals (JAZZ) Has Changed Its Investment Story
Simply Wall St · 3d ago
3 Value Stocks We’re Skeptical Of
Barchart · 4d ago
Jazz Pharmaceuticals Exec Makes Significant Stock Sale
TipRanks · 5d ago
Jazz Pharmaceuticals SVP Technical Operations Mary Elizabeth Henderson Reports Sale of Common Shares
Reuters · 5d ago
Jazz Pharmaceuticals Files Initial Beneficial Ownership Statement for Director Ted W. Love
Reuters · 6d ago
More
About JAZZ
Jazz Pharmaceuticals plc is a global biopharmaceutical company. It is engaged in developing medicines for people with serious diseases, often with limited or no therapeutic options. It has a diverse portfolio of marketed medicines, including therapies for sleep disorders and epilepsy, and a portfolio of cancer treatments. Its lead-marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Ziihera (zanidatamab-hrii), and Enrylaze (recombinant crisantaspase). Its product candidates include Zanidatamab, Vyxeos, JZP815, JZP898, JZP441, and others. Xywav is used for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy. The Company, through Chimerix, Inc., also owns a clinical asset, dordaviprone, a novel small molecule treatment in development for H3 K27M-mutant diffuse glioma.

Webull offers Jazz Pharmaceuticals PLC stock information, including NASDAQ: JAZZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAZZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAZZ stock methods without spending real money on the virtual paper trading platform.